CCND3 and non-small cell lung carcinoma: (a) Inhibits autocrine or paracrine pathways; (b) decreases tumor cyclin D3, cyclin E, and cyclin B expression; (c) inhibits AMPK/mTOR pathway signaling in NSCLC cells